Why This Beaten-Down Marijuana Stock Might Still Be a Buy

Despite recent headwinds, Hexo Corp (TSX:HEXO)(NYSE:HEXO) is still worth considering; here is why.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Hexo (TSX:HEXO)(NYSE:HEXO) hasn’t escaped the recent struggles in the marijuana industry. The company has shed some 48% of its value since late April, as the largest pot firms were losing altitude with astonishing speed. However, much like other marijuana companies, there are reasons to be bullish on Hexo’s prospects. The pot grower recently got a nice boost in the form of an analyst recommendation, which helped Hexo’s stock pop by about 10% on Friday. Analyst recommendations aside, though, here is why Hexo is far from throwing in the towel in the vast and competitive marijuana sector.

Truss beverages 

Hexo made a lot of noise earlier in the year. The firm acquired another marijuana company by the name of Newstrike Brands for $263 million. One of the motivating factors behind this acquisition was the fact that it would help Hexo increase its peak production capacity to about 150,000 kg per year. Also, Hexo holds a leading share of the cannabis market in Quebec. This is due to the company signing a five-year preferred supplier agreement to supply a total of about 200,000 kg of pot over the five-year period. This deal is the largest such provincial agreement to date, and it tips the balance in Hexo’s favor.

Despite these encouraging signs, the best argument for why Hexo is still worth considering is its partnership with beverage maker Molson Coors Brewing. The two firms penned a deal to start a joint venture to produce and sell cannabis-infused drinks. This venture goes by the name of Truss Beverages, and it represents an opportunity for Hexo to significantly improve its financial results. After a long and arduous wait, the cannabis derivative market will finally open in Canada, which means pot companies will be able to benefit from several high-margin opportunities. Hexo has been preparing for this for months. Its partnership with a firm of the caliber of Molson Coors — with its expertise in the industry, its distribution network, and its deep pockets — puts the Quebec-based marijuana company ahead of most of its peers. 

It is important to note that Hexo will be competing with none other than Canopy Growth in this market. After all, Canopy also has a partnership with a beverage maker. However, Hexo is planning to seek other avenues for growth. For instance, the firm is looking to enter the edibles segment by making gummies available to its customers, as the company’s CEO noted in a recent earnings call. Finally, Hexo is looking to dip its toes in the lucrative vaping market, which has been gaining steam recently and promises to be one of the liveliest in the cannabis derivative market.

The bottom line

Hexo is well positioned to profit from the launch of derivative products in Canada, which makes the firm worth considering, despite its recent struggles. Of course, a lot can still go wrong, but for those willing to take a little risk, Hexo might be one of the better options in the marijuana sector. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »